Skip to main content
Premium Trial:

Request an Annual Quote

Innovate UK Grants University of Oxford, ATDBio £370K for Single-Cell Sequencing Tech Development

NEW YORK – Synthetic oligonucleotide manufacturer ATDBio and researchers from the University of Oxford have won a £369,632 ($480,084) grant from Innovate UK to develop tagged microbeads for use in single-cell RNA sequencing library preparation.

ATDBio will develop improved oligonucleotide tagged beads, "which will help enhance the quality of the sequencing results and enable new types of experiments," the UK firm said in a statement on Tuesday.

Researchers led by Udo Oppermann, director of laboratory sciences at Oxford's Botnar Research Centre, will assess bead performance and investigate additional uses for them outside of single-cell RNA-seq.

"Our collaboration with the University of Oxford began in response to frequent comments from our customers about the need for improved droplet-based scRNA-seq microbeads," ATDBio CSO Tom Brown said in a statement. "This grant from Innovate UK allows ATDBio to use its oligonucleotide synthesis expertise to make the technology more effective and more accessible to researchers and clinicians."

ATDBio has laboratories in Southampton and Oxford.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.